Traditional lung cancer biomarkers NSE, SCC, and Pro-GRP can significantly improve the performance of 4MP in the differentiation of LADC, SQCLC, and SCLC, which is expected to contribute to the accurate diagnosis and personalized treatment of patients with lung cancer. The gene discussed is GRP; the disease is lung cancer.